Bioadaptives, Inc. (BDPT) Operating Margin (2016 - 2026)

Bioadaptives (BDPT) posted Operating Margin of 3594.81% for Q1 2026, down 51.07% sequentially from 2379.56% in Q4 2025.

Bioadaptives, Inc. (BDPT) Operating Margin (2016 - 2026) Analysis & Trends

Bioadaptives has reported Operating Margin for 9 years, with the latest figure at 3594.81% in Q1 2026.

Quarterly Operating Margin changed N/A year-over-year to 3594.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4166.29% (up 11456053.0% YoY) and the FY2025 annual result came in at 5701.79%, down 94932.0% from the prior year.
Operating Margin slipped to 3594.81% in Q1 2026 per BDPT's latest filing, from 2379.56% in the prior quarter.
Over five years, Operating Margin peaked at 415.47% in Q1 2024 and troughed at 13774.52% in Q2 2024.
A 5-year average of 3459.62% and a median of 2385.78% in 2023 frame the typical range for Operating Margin.
The sharpest annual moves came in 2024 and 2025: Operating Margin tumbled 1138251 bps in 2024, then surged 510043 bps in 2025.
Over 5 years, Operating Margin stood at 685.29% in 2022, then retreated by 25 bps to 857.99% in 2023, then tumbled by 1505 bps to 13774.52% in 2024, then soared by 83 bps to 2379.56% in 2025, then slumped by 51 bps to 3594.81% in 2026.
According to Business Quant data, Operating Margin over the past three periods registered 3594.81%, 2379.56%, and 5735.95% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Download Data